Convatec Group PLC (LON:CTEC) Stock Has Average Price Target of GBX 305.44 According to Analysts

Convatec Group PLC (LON:CTEC) has been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 305.44.

A number of research firms have recently weighed in on CTEC. Berenberg Bank dropped their price objective on Convatec Group from GBX 340 to GBX 335 and set a “buy” rating for the company in a research note on Friday, September 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 target price on shares of Convatec Group in a report on Wednesday, August 5th. Peel Hunt reaffirmed an “add” rating and set a GBX 270 price target on shares of Convatec Group in a research report on Tuesday, August 4th. Jefferies Financial Group reissued a “buy” rating and set a GBX 300 price objective on shares of Convatec Group in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a GBX 315 target price on shares of Convatec Group in a research note on Monday, August 3rd.

Insider Buying and Selling

In other news, insider Tobias Hestler acquired 50,000 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of GBX 226 per share, with a total value of £113,000. 0.98% of the stock is currently owned by corporate insiders.

Convatec Group Stock Down 0.1%

CTEC stock opened at GBX 216.60 on Monday. The company has a quick ratio of 0.96, a current ratio of 1.93 and a debt-to-equity ratio of 121.83. The firm has a market capitalization of £4.21 billion, a PE ratio of 34.94, a P/E/G ratio of 0.93 and a beta of 0.77. Convatec Group has a twelve month low of GBX 193 and a twelve month high of GBX 259.30. The stock’s 50 day moving average is GBX 223.98 and its 200-day moving average is GBX 217.88.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.